Heart Rhythm Clinical Research Solutions

Outdated EP data doesn’t reflect real patients. Founded in 2019, HRCRS turns real-world data into actionable insights—powering smarter decisions, faster innovation, and better outcomes across the product lifecycle. Join our learning ecosystem. DM  to connect.

HRCRS runs on a network of 270+ physicians and partners, so evidence is collaborative and measurable. We generate real-world data through dynamic registries and share learnings via publications, abstracts, and education. Want to plug in? DM us.

New REAL-AF registry data show Vein of Marshall ethanol ablation is safe and associated with lower arrhythmia recurrence in persistent AF. Study led by Drs. @Nicky_P_MD and @DanielAlyeshmer. Published in a @hrs_journal. 🔗 Link in comments:

Heading to #CRT2026? Connect with Maggi Savo, Director of Business Development at HRCRS! We design smarter Real-World Evidence studies with end-to-end CRO execution and deep cardiovascular expertise. @CRT_meeting

Back from a remarkable AF Symposium 2026 in Boston, and we are more energized than ever by the opportunity ahead! We’re grateful for the partners, innovators, and clinical leaders who spent time with us this week, and we’re excited to turn those conversations into action.

As promised, clinical data and real-world experience were front and center at #AFSymposium2026!   Thank you to @seiiwaiEPmd for a compelling Spotlight Session and to  @SaumilOzaMD for highlighting important data from the VITAL-EP registry. We appreciate your leadership and collaboration in moving the field forward in a meaningful way.   And, thank you to everyone who stopped by the Vektor booth to connect with our team. The conversations and questions were energizing and insightful.   Next up: Western AFib later this month and HRS 2026 in April.   #WAFIB2026 #HRS2026 #electrophysiology #vMap

#News: We’re kicking off #AFSymposium2026 with exciting news — new results from the multicenter VITAL-EP Registry that highlight how #vMap can support fast, low-fluoroscopy AF ablation workflows across paroxysmal, persistent, and longstanding persistent AF. Full details in the press release: businesswire.com/news/home/2026… Early findings show: ☑️Median PVI+ procedure time: ~70 minutes ☑️Median fluoroscopy time: 0 minutes ☑️Median mapping time: <10 minutes 🔦 Spotlight Session | TODAY at 8:30 AM | AF Symposium: Dr. @seiiwaiEPmd will share his clinical experience using non-invasive mapping of AF drivers to guide more comprehensive ablation strategies, highlighting how patient-specific atrial activation maps can inform decisions beyond PVI. 📍 Visit us at Booth 208 to learn more about the VITAL-EP findings and what’s new with vMap. We’re showcasing new atrial flutter capabilities that expand vMap’s non-invasive analysis to distinguish typical and atypical atrial flutter using a standard 12-lead ECG, enabling more comprehensive arrhythmia evaluation on a single platform. #eplab #electrophysiology #cardiology

The VITAL EP Registry explores the use of vMap for AF ablation. New data will be shared at the 2026 AF Symposium. 📍Omni Boston at the Seaport 🗓️ February 5-7

We’re proud to announce Keith Hebert as the new COO of HRCRS, a 3PH Alliance Company. With 27 years in clinical research, Keith brings a strong commitment to operational excellence and purpose-driven impact. A new chapter begins! Congratulations, Keith!

The VARISURE Retrospective Survey offers a first look, presented at the 31 st AF Symposium. Backed by real-world results, this data helps us better understand the role of innovation in atrial fibrillation care.

A closer look at zero-fluoroscopy workflows and the safety of circular catheters in AF ablation. That’s what the REAL AF Registry brings to this year’s AF Symposium. Two important studies: 📍AF Symposium 2026 🗓️February 5-7 | Boston

The DISRUPT AF Registry will be featured at #AFSymposium2026, and so will new insights on pulsed field ablation using the pentaspline catheter. From procedural safety to real-world workflows and recurrence, these studies show the growing value of clinical evidence in innovation.

27+ years of global clinical research, and still pushing boundaries. At HRCRS, Keith Hebert leads with strategy, innovation, and a passion for evidence that transforms care. Meet the people behind the science.

Your embedded RWE partner. HRCRS delivers clarity and clinical impact: • Onboarded nationwide EP network • Fast startup—less paperwork • Audit-ready multicenter data from day one (prospective or retrospective) Learn more: hrcrs.com

New data from the Disrupt AF Registry (lead by Dr. Amin Al-Ahmad) shows same day discharge after PFA for AF was commonly planned (81%) and successful (93% of those), with low acute complication rates (0.7%), similar to non-SDD. Full publication in comments.

Understanding PVCs Dr. Amit Thosani explains what premature ventricular contractions are,  and why they cause that “skip” or irregular heartbeat feeling. 🎥 Watch the full video here: hrcrs.com/video/Are%20PV…

Dr. @aalahmadmd will present DISRUPT AF data at #APHRS. Join us in Yokohama as we collaborate to drive innovation and improve patient outcomes in electrophysiology. @APHRSOfficial

The #REALAF registry will be at #APHRS2025 in Yokohama, Japan: a global gathering of leaders in heart rhythm innovation. @APHRSOfficial